TY - JOUR T1 - Emerging Drug Therapies for Heart Failure TT - JF - iums-ijpt JO - iums-ijpt VL - 5 IS - 2 UR - http://ijpt.iums.ac.ir/article-1-100-en.html Y1 - 2006 SP - 87 EP - 0 KW - Heart failure KW - Candisartan KW - Spironolactone KW - Conivaptan KW - Nesiritide KW - Omapatrilat N2 - Heart failure is associated with high morbidity and mortality and is proving to be an economic burden in developing countries. A number of therapeutic agents are presently employed in heart failure; but they are not sufficient to control symptoms of heart failure. Moreover, the prevalence of chronic heart failure is progressively increasing and thus there is a continuing need to develop effective therapies for the management of this disease. The present review has discussed various potential therapeutic agents which may open new vistas for the management of heart failure. M3 ER -